TLR regulation of SPSB1 controls inducible nitric oxide synthase induction

Rowena Lewis, Tatianna Kolesnik, Zhihe Kuang, Akshay D'Cruz, Marnie Blewitt, Seth Masters, Andrew Low, Tracy Willson, Raymond Norton, Sandra Nicholson

Research output: Contribution to journalArticleResearchpeer-review

49 Citations (Scopus)


The mammalian innate immune system has evolved to recognize foreign molecules derived from pathogens via the TLRs. TLR3 and TLR4 can signal via the TIR domain-containing adapter inducing IFN-beta (TRIF), which results in the transcription of a small array of genes, including IFN-beta. Inducible NO synthase (iNOS), which catalyzes the production of NO, is induced by a range of stimuli, including cytokines and microbes. NO is a potent source of reactive nitrogen species that play an important role in killing intracellular pathogens and forms a crucial component of host defense. We have recently identified iNOS as a target of the mammalian SPSB2 protein. The SOCS box is a peptide motif, which, in conjunction with elongins B and C, recruits cullin-5 and Rbx-2 to form an active E3 ubiquitin ligase complex. In this study, we show that SPSB1 is the only SPSB family member to be regulated by the same TLR pathways that induce iNOS expression and characterize the interaction between SPSB1 and iNOS. Through the use of SPSB1 transgenic mouse macrophages and short hairpin RNA knockdown of SPSB1, we show that SPSB1 controls both the induction of iNOS and the subsequent production of NO downstream of TLR3 and TLR4. Further, we demonstrate that regulation of iNOS by SPSB1 is dependent on the proteasome. These results suggest that SPSB1 acts through a negative-feedback loop that, together with SPSB2, controls the extent of iNOS induction and NO production. The Journal of Immunology, 2011, 187: 3798-3805.
Original languageEnglish
Pages (from-to)3798 - 3805
Number of pages8
JournalJournal of Immunology
Issue number7
Publication statusPublished - 2011

Cite this